These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 15207785)

  • 21. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
    Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
    Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease.
    Figueroa C; Peralta A; Herrera L; Castro P; Gutiérrez A; Valenzuela J; Aguillón JC; Quera R; Hermoso MA
    Eur Cytokine Netw; 2006 Jun; 17(2):125-30. PubMed ID: 16840031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
    Oostenbrug LE; Nolte IM; Oosterom E; van der Steege G; te Meerman GJ; van Dullemen HM; Drenth JP; de Jong DJ; van der Linde K; Jansen PL; Kleibeuker JH
    Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease.
    Baumgart DC; Buning C; Geerdts L; Schmidt HH; Genschel J; Fiedler T; Gentz E; Molnar T; Nagy F; Lonovics J; Lochs H; Wiedenmann B; Nickel R; Witt H; Dignass A
    Digestion; 2007; 76(3-4):196-202. PubMed ID: 18174680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNF-alpha promoter, Nod2 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin.
    Schippers EF; van 't Veer C; van Voorden S; Martina CA; le Cessie S; van Dissel JT
    Cytokine; 2004 Apr; 26(1):16-24. PubMed ID: 15016407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DLG5 variants in inflammatory bowel disease.
    Büning C; Geerdts L; Fiedler T; Gentz E; Pitre G; Reuter W; Luck W; Buhner S; Molnar T; Nagy F; Lonovics J; Dignass A; Landt O; Nickel R; Genschel J; Lochs H; Schmidt HH; Witt H
    Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage migration inhibitory factor, Toll-like receptor 4, and CD14 polymorphisms with altered expression levels in patients with ulcerative colitis.
    Sivaram G; Tiwari SK; Bardia A; Anjum F; Vishnupriya S; Habeeb A; Khan AA
    Hum Immunol; 2012 Feb; 73(2):201-5. PubMed ID: 22192785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
    Brand S; Staudinger T; Schnitzler F; Pfennig S; Hofbauer K; Dambacher J; Seiderer J; Tillack C; Konrad A; Crispin A; Göke B; Lohse P; Ochsenkühn T
    Inflamm Bowel Dis; 2005 Jul; 11(7):645-52. PubMed ID: 15973118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis.
    Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Peyvandi F; Bossa F; Zagaria C; Andriulli A; Devoto M; Annese V
    Aliment Pharmacol Ther; 2006 Feb; 23(4):497-506. PubMed ID: 16441470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The G2964A polymorphism of the STAT6 gene in inflammatory bowel disease.
    Klein W; Tromm A; Folwaczny C; Hagedorn M; Duerig N; Epplen J; Schmiegel W; Griga T
    Dig Liver Dis; 2005 Mar; 37(3):159-61. PubMed ID: 15888279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status.
    Braun C; Zahn R; Martin K; Albert E; Folwaczny C
    Clin Immunol; 2001 Dec; 101(3):357-60. PubMed ID: 11726228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia.
    Newport MJ; Allen A; Awomoyi AA; Dunstan SJ; McKinney E; Marchant A; Sirugo G
    Tuberculosis (Edinb); 2004; 84(6):347-52. PubMed ID: 15525557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children.
    Fagerås Böttcher M; Hmani-Aifa M; Lindström A; Jenmalm MC; Mai XM; Nilsson L; Zdolsek HA; Björkstén B; Söderkvist P; Vaarala O
    J Allergy Clin Immunol; 2004 Sep; 114(3):561-7. PubMed ID: 15356557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study.
    Morange PE; Tiret L; Saut N; Luc G; Arveiler D; Ferrieres J; Amouyel P; Evans A; Ducimetiere P; Cambien F; Juhan-Vague I;
    Eur J Hum Genet; 2004 Dec; 12(12):1041-9. PubMed ID: 15367917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microsatelite GT polymorphism in the toll-like receptor 2 is associated with colorectal cancer.
    Boraska Jelavić T; Barisić M; Drmic Hofman I; Boraska V; Vrdoljak E; Peruzović M; Hozo I; Puljiz Z; Terzić J
    Clin Genet; 2006 Aug; 70(2):156-60. PubMed ID: 16879199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.
    Geleijns K; Jacobs BC; Van Rijs W; Tio-Gillen AP; Laman JD; van Doorn PA
    J Neuroimmunol; 2004 May; 150(1-2):132-8. PubMed ID: 15081257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.